Related Experiment Video
Updated: Dec 25, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
COVID-19 pandemic, coronaviruses, and diabetes mellitus
Ranganath Muniyappa1, Sriram Gubbi1
1Clinical Endocrine Section, Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Insights
Diabetes significantly impacts COVID-19 outcomes by altering host-viral interactions and immune responses. Further research is needed to understand these mechanisms and improve care for diabetic patients during the pandemic.
Area of Science:
- Virology
- Immunology
- Endocrinology
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, presents a significant global health challenge.
- Comorbidities like diabetes mellitus increase the risk of severe COVID-19 outcomes, including hospitalization and death.
- Previous research on MERS-CoV and SARS-CoV-2 highlights the complex interplay between viral infections and metabolic diseases.
Purpose of the Study:
- To explore the potential mechanisms through which diabetes influences host-viral interactions in COVID-19.
- To examine how diabetes modulates the host's immune response to SARS-CoV-2 infection.
- To identify knowledge gaps requiring further investigation regarding COVID-19 in diabetic populations.
Main Methods:
- Review of existing literature on SARS-CoV-2, MERS-CoV, and diabetes.
- Analysis of host-viral interaction pathways.
- Examination of immune response modulation in the context of diabetes and viral infections.
Main Results:
- Diabetes may alter viral entry, replication, and spread.
- Immune dysregulation in diabetic individuals can lead to exaggerated or insufficient inflammatory responses.
- Specific metabolic pathways in diabetes are implicated in modulating disease severity.
Conclusions:
- Diabetes plays a critical role in COVID-19 pathogenesis by affecting host-viral dynamics and immune surveillance.
- Understanding these mechanisms is crucial for developing targeted therapeutic strategies for diabetic patients with COVID-19.
- Further research is essential to elucidate these complex interactions and address unmet clinical needs.
Abstract:
The pandemic of coronavirus disease (COVID-19), a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is causing substantial morbidity and mortality. Older age and presence of diabetes mellitus, hypertension, and obesity significantly increases the risk for hospitalization and death in COVID-19 patients. In this Perspective, informed by the studies on SARS-CoV-2, Middle East respiratory syndrome (MERS-CoV), and the current literature on SARS-CoV-2, we discuss potential mechanisms by which diabetes modulates the host-viral interactions and host-immune responses. We hope to highlight gaps in knowledge that require further studies pertinent to COVID-19 in patients with diabetes.
More Related Videos
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Psychoneuroimmunology: Diabetes and Cancer
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Diabetes: Symptoms, Diagnosis, and Complications

